Abrilada by Catalent Indiana, LLC

Abrilada by

Drug Labeling and Warnings

Abrilada by is a Prescription medication manufactured, distributed, or labeled by Catalent Indiana, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ABRILADA- adalimumab-afzb injection, solution 
Catalent Indiana, LLC

----------

127-102-303 0.4mLCarton127-102-303 0.4mLCase

ABRILADA 
adalimumab-afzb injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 61434-053
Route of AdministrationSUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ADALIMUMAB-AFZB (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-AFZB20 mg  in 0.4 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 61434-053-0040 in 1 CASE01/14/2021
12 in 1 CARTON
10.4 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
export only01/14/202109/26/2023
Labeler - Catalent Indiana, LLC (172209277)

Revised: 9/2023
Document Id: 16c2517e-623a-4c5c-a714-017c71f65d5d
Set id: f2ee682a-8ea6-4068-bdbe-8a9e7d1a2514
Version: 7
Effective Time: 20230926
 

Trademark Results [Abrilada]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ABRILADA
ABRILADA
90229278 not registered Live/Pending
Pfizer Inc.
2020-10-01
ABRILADA
ABRILADA
88907943 not registered Live/Pending
Pfizer Inc.
2020-05-08
ABRILADA
ABRILADA
87482653 not registered Live/Pending
Pfizer Inc.
2017-06-09
ABRILADA
ABRILADA
86578635 not registered Dead/Abandoned
Pfizer Inc.
2015-03-27
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.